Wednesday saw quite the sell-off. It was rather scary because it happened so fast. However, the good news was that the S&P 500 index found support at an important short-term level, and the market seemed to become very oversold.

Pfizer Inc. recently released its full-year 2025 guidance and reaffirmed its 2024 outlook, aligning with Street expectations. It seems having faith in the company may have paid off.

In this short video, I discuss how to navigate the highs and lows of market volatility with strategies that balance risk and reward.

In this video, we dive deep into the world of options trading, investment strategies, and wealth-building tactics to consider.

Gold traders have been through a lot over the last couple of days, as the space fluctuated rapidly. The holiday season is approaching, and therefore I think liquidity will be thin and the market will continue to experience back-and-forth movement.

The non-ferrous mining industry looks bleak as weak demand in China has weighed on metal prices. However, the demand for non-ferrous metals is expected to be supported by the energy-transition trend. Thus, it may be wise to consider these stocks.

The Celanese Corporation cut its dividend because of continued weakness in the Chinese economy, weak demand in the automotive and construction end markets, and too much debt from an acquisition. It previously had a 15-year streak of increases.

The options expiration seen on Friday clouded the volume picture, but buyers built some momentum into the Santa rally. The FOMC rate statement put a huge dent in prior rallies. Although it was the Russell 2000 that found itself most on the back foot.